|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/4/2008 9:41:25 AM
BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today that its chief scientist, Professor David Glover, will participate in a Symposium on "Pharmacologic Regulation of DNA Damage Checkpoints to Treat Cancer." The event will take place on Thursday, March 13, 2008 from 1:00 pm to 5:30 pm Eastern time at The New York Academy of Sciences (NYAS), located at 7 World Trade Center, 250 Greenwich Street, New York, NY.
|
|
|
|
|
|
|
|
|
|
|